IFN-γ, for example, induces PD-L1 expression in a dose-dependent manner, which raises concerns, as cytokine-secreting antitumor immune cells may produce a cancer cell defensive response that blocks immunity [13, 14]. The gene discussed is CD274; the disease is cancer.